MedPath

AbelZeta Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Phase 1
Not yet recruiting
Conditions
Lupus Nephritis (LN)
Interventions
First Posted Date
2025-04-20
Last Posted Date
2025-04-24
Lead Sponsor
AbelZeta Inc.
Target Recruit Count
24
Registration Number
NCT06935474
Locations
🇺🇸

AbelZeta, Inc., Rockville, Maryland, United States

C-TIL051 in Non-Small Cell Lung Cancer

Phase 1
Recruiting
Conditions
Metastatic Non Small Cell Lung Cancer
Interventions
First Posted Date
2023-01-09
Last Posted Date
2024-10-04
Lead Sponsor
AbelZeta, Inc.
Target Recruit Count
20
Registration Number
NCT05676749
Locations
🇺🇸

UC San Diego Moores Cancer Center, La Jolla, California, United States

🇺🇸

Ochsner MD Anderson Cancer Center, New Orleans, Louisiana, United States

🇺🇸

Duke Center for Cancer Immunotherapy, Raleigh, North Carolina, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath